Cat. #162213
Anti-GFAP PAb
Cat. #: 162213
Sub-type: Primary antibody
Unit size: 100 ug
Target: glial fibrillary acidic protein GFAP
Class: Polyclonal
Application: WB ; IP ; IHC
Reactivity: Human
£300.00
This fee is applicable only for non-profit organisations. If you are a for-profit organisation or a researcher working on commercially-sponsored academic research, you will need to contact our licensing team for a commercial use license.
Contributor
Inventor: Roy Quinlan
Institute: University of Durham
Primary Citation: Der Perng M, et al. 2006. Am J Hum Genet. 79(2):197-213. PMID: 16826512.
Tool Details
*FOR RESEARCH USE ONLY (for other uses, please contact the licensing team)
- Name: Anti-GFAP PAb
- Alternate name: GFAP
- Research fields: Cell biology
- Tool sub type: Primary antibody
- Class: Polyclonal
- Conjugation: Unconjugated
- Molecular weight: 51kDa, 432 residues
- Reactivity: Human
- Application: WB ; IP ; IHC
- Description: This is a site specific polyclonal antibody, recognising a domain that is key to the assembly of GFAP. The site is contained within exon 9, and therefore allows the identification of GFAP splice variants (Buniatian GH et al). Glial fibrillary acidic protein-positive cells of the kidney are capable of raising a protective biochemical barrier similar to astrocytes: expression of metallothionein in podocytes (de Reus AJEM et al 2024).
- Immunogen: peptide crosslinked to KLH
- Isotype: IgG
Target Details
- Target: glial fibrillary acidic protein GFAP
- Target alternate names: GFAP
- Molecular weight: 51kDa, 432 residues
- Target background: GFAP is an intermediate filament that is expressed in astrocytes. Intermediate filaments are a distinct group of cytoskeletal molecules.
Applications
- Application: WB ; IP ; IHC
Handling
- Format: Liquid
- Concentration: 1mg/ml
- Unit size: 100 ug
- Storage buffer: Serum plus azide (0.02%)
- Storage conditions: -80° C
- Shipping conditions: Dry ice
References
- Naru J, et al. 2017. J Proteomics. 21
- 159:77-91. PMID: 28232133.
